                                 FINAL REPORT
 INDICATION:   Ms. ___ is a ___ F with Sarcoidosis w/ lung/skin involvement
 on methotrexate and methylprednisolone, also h/o + ANCA, w/ worsening hypoxia
 // Is there change in her opacities?
 
 TECHNIQUE:  Upright PA and lateral chest
 
 COMPARISON:  Chest radiographs ___ through ___. CT chest
 ___
 
 FINDINGS: 
 
 There has been interval progression of severe bilateral interstitial
 opacities.  Mild cardiomegaly is unchanged.  The mediastinal and hilar
 contours are stable. There is no pleural effusion or pneumothorax.
 
 IMPRESSION: 
 
 Interval progression of severe bilateral interstitial opacities. This could be
 due to sarcoidosis but superimposed chronic interstitial lung disease related
 to drug reaction cannot be excluded.
